EFTA01922261

To: From: Jeffrey E. Sent Mon 6/16/2014 4:41:35 PM Subject Re: Joe Thakuria? Yes check On Monday, June 16, 2014 wrote: I asked Rich if he has paid anything to Joe Thakuria, but he has received no invoice...do you want me to check with Joe if he will be sending an invoice soon? Begin forwarded message: From: "Jeffrey E." <jeevacationalamail.com> Subject: Re: Joe Thakuriall/ll Date: June 5, 2014 3:43:45 PM EDT To Mine first the fund On Thursday, June 5, 2014, Begin forwarded message: From: Joseph Thakuria Subject: Re: Jeffrey Epci ein Date: June 5, 2014 at 3:34:41 PM EDT Hi= Sony for the delayed response. We just got word from the IRB and we're finally ready to push forward with the YPO study. > wrote: I wanted to discuss a couple things with Jeffrey by phone at his convenience including: a) getting a whole genome through Illumina puts him a little bit outside of the workflow pipeline for the YPO project. Ie, those participants are paying $1000 each and will be getting their exomes sequenced through Ambry, a thumbnail drive of their compressed genomic data, and an annotated report of 56 ACMG gene hits. I think it's worth getting him into this queue as well so he goes through the same pipeline as the YPO folks and others in our study. Last time I EFTA_R1_00366203 EFTA01922261 discussed with him he definitely wanted a whole genomes through IIlumina for —$11,000 (which is still fine) but would he be interested in also getting the $1000 exome to also go through the normal pipeline? Although the exome data should be redundant with the whole genome data, I think it's worth it for the thumbnail drive and the ACMG gene summary. We'll also be able to check for concordance between the 2 datasets. b) Jeffrey has samples (including fibroblast cell culture from his skin biopsy) at HMS. Do I have his permission to request these samples from the PGP for inclusion in the YPO study? (The samples can be used for both studies if he wishes.) Our YPO study may need a self-collected saliva sample for which I can mail him a kit. So, I wanted to discuss these sample issues with him as well. c) Lastly, we actually still need some bioinformatic and genetic counselor support for the YPO study - not just for his sample but all of our 80 plus YPO study subjects (from the Austin chapter). As I mentioned, all 80+ have already paid $1000 each for the sequencing but we still need to cover bioinformatics and a part-time GC for all particpants. In the past, months ago now do to the IRB delay, Jeffrey was generous enough to offer to pay for sequencing of YPO members. Since that's already covered, I'm wondering if he would consider donating financial support for bioinformatic infrastructure for this study. I'm available to discuss later this evening. Tomorrow and this weekend are also relatively open for a brief call. My cell is 917-774-3346. Thanks in advance for passing on this message. We're excited to finally be moving forward with our innovative study. Best, Joe On Thu, May 29, 2014 at 1:29 PM, wrote: Hello Joe! Hope you are well and enjoyed the Memorial Day weekend...Jeffrey is asking if you have been able to submit his sample as of yet? Can you let me know where we stand? Thanks, EFTA_R1_00368204 EFTA01922262 please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any pan thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jecvacation@gmail,com, and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA_R1_00368205 EFTA01922263